Hall SD[au] - Search Results

Year	Number of Results
1978	1
1984	2
1986	3
1987	2
1988	3
1989	3
1990	2
1991	5
1992	10
1993	4
1994	7
1995	4
1996	4
1997	4
1998	8
1999	4
2000	8
2001	7
2002	9
2003	6
2004	10
2005	13
2006	6
2007	9
2008	11
2009	12
2010	9
2011	7
2012	9
2013	13
2014	10
2015	8
2016	3
2017	10
2018	8
2019	7
2020	4
2021	2
2022	0

1

Irreversible Enzyme Inhibition Kinetics and Drug-Drug Interactions.

Mohutsky M, Hall SD. Mohutsky M, et al. Among authors: hall sd. Methods Mol Biol. 2021;2342:51-88. doi: 10.1007/978-1-0716-1554-6_3. Methods Mol Biol. 2021. PMID: 34272691

2

Irreversible enzyme inhibition kinetics and drug-drug interactions.

Mohutsky M, Hall SD. Mohutsky M, et al. Among authors: hall sd. Methods Mol Biol. 2014;1113:57-91. doi: 10.1007/978-1-62703-758-7_5. Methods Mol Biol. 2014. PMID: 24523109 Review.

3

Overview of the Genetics of Alcohol Use Disorder.

Tawa EA, Hall SD, Lohoff FW. Tawa EA, et al. Among authors: hall sd. Alcohol Alcohol. 2016 Sep;51(5):507-14. doi: 10.1093/alcalc/agw046. Epub 2016 Jul 21. Alcohol Alcohol. 2016. PMID: 27445363 Free PMC article. Review.

4

A Systematic Review of Neurofeedback for the Management of Motor Symptoms in Parkinson's Disease.

Anil K, Hall SD, Demain S, Freeman JA, Ganis G, Marsden J. Anil K, et al. Among authors: hall sd. Brain Sci. 2021 Sep 29;11(10):1292. doi: 10.3390/brainsci11101292. Brain Sci. 2021. PMID: 34679358 Free PMC article. Review.

5

Disease-Drug Interactions in Inflammatory States via Effects on CYP-Mediated Drug Clearance.

Coutant DE, Hall SD. Coutant DE, et al. Among authors: hall sd. J Clin Pharmacol. 2018 Jul;58(7):849-863. doi: 10.1002/jcph.1093. Epub 2018 Mar 5. J Clin Pharmacol. 2018. PMID: 29505093 Review.

6

Quantitative Prediction of CYP3A4- and CYP3A5-Mediated Drug Interactions.

Guo Y, Lucksiri A, Dickinson GL, Vuppalanchi RK, Hilligoss JK, Hall SD. Guo Y, et al. Among authors: hall sd. Clin Pharmacol Ther. 2020 Jan;107(1):246-256. doi: 10.1002/cpt.1596. Epub 2019 Sep 12. Clin Pharmacol Ther. 2020. PMID: 31356678 Free PMC article. Clinical Trial.

7

Understanding Disease-Drug Interactions in Cancer Patients: Implications for Dosing Within the Therapeutic Window.

Coutant DE, Kulanthaivel P, Turner PK, Bell RL, Baldwin J, Wijayawardana SR, Pitou C, Hall SD. Coutant DE, et al. Among authors: hall sd. Clin Pharmacol Ther. 2015 Jul;98(1):76-86. doi: 10.1002/cpt.128. Epub 2015 May 19. Clin Pharmacol Ther. 2015. PMID: 25808023 Review.

8

Drug-drug interaction prediction assessment.

Zhou J, Qin Z, Sara QK, Kim S, Wang Z, Hall SD, Li L. Zhou J, et al. Among authors: hall sd. J Biopharm Stat. 2009 Jul;19(4):641-57. doi: 10.1080/10543400902964084. J Biopharm Stat. 2009. PMID: 20183431

9

Physiologically based pharmacokinetic modeling in drug discovery and development: a pharmaceutical industry perspective.

Jones HM, Chen Y, Gibson C, Heimbach T, Parrott N, Peters SA, Snoeys J, Upreti VV, Zheng M, Hall SD. Jones HM, et al. Among authors: hall sd. Clin Pharmacol Ther. 2015 Mar;97(3):247-62. doi: 10.1002/cpt.37. Epub 2015 Jan 9. Clin Pharmacol Ther. 2015. PMID: 25670209 Review.

10

Abemaciclib Inhibits Renal Tubular Secretion Without Changing Glomerular Filtration Rate.

Chappell JC, Turner PK, Pak YA, Bacon J, Chiang AY, Royalty J, Hall SD, Kulanthaivel P, Bonventre JV. Chappell JC, et al. Among authors: hall sd. Clin Pharmacol Ther. 2019 May;105(5):1187-1195. doi: 10.1002/cpt.1296. Epub 2018 Dec 30. Clin Pharmacol Ther. 2019. PMID: 30449032 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results